STERIS plc (NYSE: STE) furnishes fiscal 2026 Q3 results press release

Rhea-AI Filing Summary

STERIS plc filed a current report stating that it has released financial results for its fiscal 2026 third quarter, covering the quarter ended December 31, 2025. The company announced these results through a press release dated February 4, 2026, which is attached as Exhibit 99.1 and furnished, rather than filed, with regulators.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001757898Dublin 2,falseD02 R2962026-02-04353001-38848L2falsefalsefalse00017578982026-02-042026-02-0400017578982025-11-052025-11-050001757898ste:OrdinarySharesMember2026-02-042026-02-040001757898ste:STETwo700SeniorNotesDue2031MemberMember2026-02-042026-02-040001757898ste:Two700SeniorNotesDue2051MemberMember2026-02-042026-02-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 4, 2026

STERIS plc

(Exact Name of Registrant as Specified in Charter)

Ireland

001-38848

98-1455064

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(IRS Employer Identification No.)

70 Sir John Rogerson's Quay,			Dublin 2,			Ireland			D02 R296
(Address of principal executive offices)

Registrant’s telephone number, including area code: + 353 1 232 2000

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Ordinary Shares, $0.001 par value			STE			New York Stock Exchange
2.700% Senior Notes due 2031			STE/31			New York Stock Exchange
3.750% Senior Notes due 2051			STE/51			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02 Results of Operations and Financial Condition.

On February 4, 2026, STERIS plc (the “Company”) issued a press release announcing its financial results for the quarter ended December 31, 2025. A copy of this press release is attached hereto as Exhibit 99.1.

The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section. Furthermore, the information contained in this Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.						Description
99.1						Press Release issued by STERIS plc on February 4, 2026 announcing financial results for its fiscal 2026 third quarter ending December 31, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

STERIS plc
By						/s/ J. Adam Zangerle
Name:						J. Adam Zangerle
Title:						Senior Vice President, General Counsel & Company Secretary

Dated: February 4, 2026

FAQ

What did STERIS plc (STE) disclose in its latest 8-K filing?

STERIS plc disclosed that it issued a press release announcing financial results for its fiscal 2026 third quarter, covering the quarter ended December 31, 2025. The press release is attached as Exhibit 99.1 and is being furnished to regulators.

Which period do STERIS plc’s newly announced results in the 8-K cover?

The results announced by STERIS plc cover its fiscal 2026 third quarter, specifically the quarter ended December 31, 2025. These results are described in a press release dated February 4, 2026, which is included as Exhibit 99.1 to the report.

How is STERIS plc’s third-quarter earnings press release treated in the 8-K?

The press release announcing STERIS plc’s fiscal 2026 third-quarter results is being furnished under Item 2.02, rather than filed. This means it is not subject to Section 18 liabilities and is not automatically incorporated into Securities Act registration statements.

Where can investors find STERIS plc’s detailed fiscal Q3 2026 results?

Investors can find detailed fiscal Q3 2026 results in the press release attached as Exhibit 99.1 to the 8-K. The filing notes that this press release, dated February 4, 2026, contains the company’s financial results for the quarter ended December 31, 2025.

Does the STERIS plc 8-K incorporate the earnings press release into other filings?

No. The 8-K explicitly states that the information in Item 2.02, including Exhibit 99.1, is not deemed filed under Section 18 and will not be incorporated by reference into any Securities Act registration statement or other documents.

Who signed the STERIS plc 8-K related to fiscal 2026 third-quarter results?

The report was signed on behalf of STERIS plc by J. Adam Zangerle, the company’s Senior Vice President, General Counsel and Company Secretary. The signature confirms the company’s authorization of the furnished third-quarter financial results press release.